Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03814278
Other study ID # RPM-PT_Estudo_Repouso
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2012
Est. completion date January 2018

Study information

Verified date January 2019
Source Centro Hospitalar Lisboa Norte
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Antepartum bed rest is widely prescribed after preterm premature rupture of the membranes (PPROM), although its effectiveness to prevent preterm birth has not been demonstrated. This pilot randomized controled trial (RCT) aims to access the impact of bed rest in maternal and neonatal outcomes in pregnancies complicated by premature rupture of the membranes.


Description:

Aims - To access the impact of bed rest in latency time to delivery, chorioamnionitis incidence and other maternal and neonatal outcomes in pregnancies complicated by PPROM, thus enabling proper sample size calculation for future powered RCT.

Study population and Sample size - Eligible patients included those with single pregnancies with PPROM at 24+0-33+6 weeks of gestation who were admitted to and delivering at our tertiary center. PPROM was diagnosed on the basis of patient's history and sterile speculum examination with visualization of amniotic fluid pooling in the vagina and/or leaking from the cervical canal. Exclusion criteria included indication for immediate delivery on admission (chorioamnionitis, placenta abruption, cord prolapse, signs of fetal hypoxia/distress), fetal malformations, multiple gestation, and maternal immunosuppressive disease. Considering future sample size calculation based upon assumed differences between groups regarding latency and infection, we aimed a sample of 30 participants.

Randomization - A pilot unblinded randomized controlled trial (RCT) in a 1:1 allocation ratio between two groups (complete bed rest versus activity restriction after PPROM). Simple random allocation sequence was generated by the investigators and implemented by sequentially numbered sealed envelopes. Participants were enrolled by physicians after hospital admission and written informed consent was obtained before randomization. The trial was conducted in a single tertiary center of the Portuguese national health system after approval by its ethical committee.

Statistical analysis - An intention-to-treat analysis was performed with a significance level of 5%.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date January 2018
Est. primary completion date December 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- single pregnancies AND

- PPROM at 24+0-33+6 weeks of gestation AND

- admitted to our tertiary center.

Exclusion Criteria:

- indication for immediate delivery on admission (chorioamnionitis, placenta abruption, cord prolapse, signs of fetal hypoxia/distress)

- fetal malformations

- multiple gestation

- maternal immunosuppressive disease

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
complete bed rest
Patients in this group received standard care for PPROM according to the institution protocol, including antepartum confinement to bed.
activity restriction
Patients in this group received standard care for PPROM according to the institution protocol but to had bathroom privileges and walks to the ward canteen four times per day.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centro Hospitalar Lisboa Norte

Outcome

Type Measure Description Time frame Safety issue
Primary Latency time Time between preterm premature rupture of the membranes and delivery, in days From preterm premature rupture of the membranes until delivery, estimated average time of one week
Primary Chorioamnionitis Incidence of clinical chorioamnionitis (defined as maternal fever plus leukocytosis and CRP elevation, or as maternal fever plus any two of the following: fetal tachycardia; maternal tachycardia; uterine tenderness; purulent amniotic fluid) From preterm premature rupture of the membranes until delivery, estimated average time of one week
See also
  Status Clinical Trial Phase
Recruiting NCT04963465 - The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT04294069 - Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial Phase 4
Recruiting NCT03976063 - Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation Phase 3
Completed NCT01503606 - Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane Phase 3
Recruiting NCT04590677 - Prediction of the Onset of Term and Preterm Labour
Recruiting NCT04110704 - Cerclage After Full Dilatation Caesarean Section N/A
Completed NCT03473210 - The Value of Amniopatch in Preterm Premature Rupture of Membranes N/A
Not yet recruiting NCT05328817 - Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes N/A
Recruiting NCT05353153 - The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support N/A
Completed NCT04807543 - Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes Phase 2
Not yet recruiting NCT05207800 - Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes
Recruiting NCT04705935 - Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
Active, not recruiting NCT06074601 - MIRACLE of LIFE Study
Recruiting NCT04516226 - Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes N/A
Recruiting NCT03306719 - mtDNA as Novel Biomarker for Intra-amniotic Infection N/A
Not yet recruiting NCT06377397 - Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates Phase 3
Completed NCT04413019 - Domiciliary Versus Hospital Management of PPROM